510(k) Report

PMA · Approved

Approved

N.C.G.T. Graft

P800058PMAApproved Sep 8, 1981340-day reviewClass III

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

St. Jude Medical, Inc. · LXA Tissue Graft Of 6mm And Greater

Approved on Sep 8, 1981 through premarket approval, which rests on the device’s own clinical evidence after a 340-day review.

Decided
Sep 8, 1981
Review
340 days
Class
Class III
Product code
LXA
Recalls
None

PMA approvals rest on their own clinical evidence and do not claim a predicate, so this family tree starts here.

P800058 has 9 supplements since 1986: changes to the approved device, its labelling or its manufacturing, each approved separately.

PMA supplements approved per year

1986: 11987: 31988: 11989: 11991: 21994: 1
1986high 3 (1987) · low 0 (1990)1994
View FIG. 1 as a table
YearSupplements approved
19861
19873
19881
19891
19912
19941
FIG. 1 — Supplements to P800058, 1986–1994Source: FDA PMA database

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA PMA database (decision fields and supplements), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LXA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

Does it have a predicate?

PMA decisions do not claim a predicate device.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All LXA devices

LXA Tissue Graft Of 6mm And Greater: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LXA

1in 2025

2007: 12008: 12009: 22010: 12012: 22013: 22014: 72015: 12016: 22017: 12018: 62020: 12022: 12023: 42024: 32025: 12026 (partial year): 2
2007high 7 (2014) · low 0 (2011)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LXA

Too few LXA 510(k)s in any year since 2007 to give a median.

Recalls per year · LXA

3in 2025

2025: 3
2007high 3 (2025) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LXA

28in 2025

2007: 22011: 12012: 12013: 32014: 62015: 92016: 112017: 132018: 112019: 132020: 32021: 62022: 82023: 122024: 162025: 28
2007high 28 (2025) · low 0 (2008)2025

MAUDE reports naming product code LXA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—02
20081—00
20092—00
20101—00
20110—01
20122—01
20132—03
20147—06
20151—09
20162—011
20171—013
20186—011
20190—013
20201—03
20210—06
20221—08
20234—012
20243—016
20251—328
20262—0—
Cite this page

510(k) Report. “P800058: N.C.G.T. Graft.” Lineage record from FDA PMA data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/P800058

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026